Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	364.22	-286.37	61.69
Graham Fair Price	-42.99	0.97	1.71
PEG	19297.10	0.58	< 0.005
Price/Book	-21.95	1.62	2.07
Price/Cash Flow	19.17	-53.56	-66.27
Prices/Earnings	132.48	-77.70	33.42
Price/Sales	150.50	19.66	7.85
Price/FCF	19.17	-53.56	-66.27
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-23.63	0.24	0.31
Operating Margin	-9.52	-0.05	0.06
ROA	-65.97	< 0.005	< 0.005
ROE	0.02	< 0.005	-66.43
ROIC	< 0.005	< 0.005	-55.62
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.06	< 0.005	1220.38
Dividends QOQ	-0.02	0.28	1086.53
EBIT QOQ	11.97	-1.28	-89.30
EPS QOQ	111.00	-1.33	-98.80
FCF QOQ	-5.13	0.04	-99.23
Revenue QOQ	1.18	-0.69	-41.36
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	58.85	216.54	267.96
Days Sales Outstanding (DSO)	201.93	566.18	180.39
Inventory Turnover	1.53	0.42	-72.82
Debt/Capitalization	0.23	0.25	4.94
Quick Ratio	1.39	1.32	-4.82
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	2.89	2.85	-1.60
Cash	0.49	0.51	3.19
Capex	-0.09	-0.02	80.93
Free Cash Flow	-0.09	-0.09	4.99
Revenue	0.76	0.23	-69.34
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.64	1.69	3.41
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	3.72	-23.72	538.49
Naive Interpretation	Member

06 - Financial Health · Weak

Rating